» Articles » PMID: 26452208

A Systems Approach Identifies Essential FOXO3 Functions at Key Steps of Terminal Erythropoiesis

Abstract

Circulating red blood cells (RBCs) are essential for tissue oxygenation and homeostasis. Defective terminal erythropoiesis contributes to decreased generation of RBCs in many disorders. Specifically, ineffective nuclear expulsion (enucleation) during terminal maturation is an obstacle to therapeutic RBC production in vitro. To obtain mechanistic insights into terminal erythropoiesis we focused on FOXO3, a transcription factor implicated in erythroid disorders. Using an integrated computational and experimental systems biology approach, we show that FOXO3 is essential for the correct temporal gene expression during terminal erythropoiesis. We demonstrate that the FOXO3-dependent genetic network has critical physiological functions at key steps of terminal erythropoiesis including enucleation and mitochondrial clearance processes. FOXO3 loss deregulated transcription of genes implicated in cell polarity, nucleosome assembly and DNA packaging-related processes and compromised erythroid enucleation. Using high-resolution confocal microscopy and imaging flow cytometry we show that cell polarization is impaired leading to multilobulated Foxo3-/- erythroblasts defective in nuclear expulsion. Ectopic FOXO3 expression rescued Foxo3-/- erythroblast enucleation-related gene transcription, enucleation defects and terminal maturation. Remarkably, FOXO3 ectopic expression increased wild type erythroblast maturation and enucleation suggesting that enhancing FOXO3 activity may improve RBCs production. Altogether these studies uncover FOXO3 as a novel regulator of erythroblast enucleation and terminal maturation suggesting FOXO3 modulation might be therapeutic in disorders with defective erythroid maturation.

Citing Articles

New insights into the mechanisms of red blood cell enucleation: From basics to clinical applications.

Zhuo Q, Zhang Z, Fang X EJHaem. 2024; 5(6):1301-1311.

PMID: 39691252 PMC: 11647694. DOI: 10.1002/jha2.1051.


Erythroblast enucleation at a glance.

Newton L, Fowler V, Humbert P J Cell Sci. 2024; 137(19).

PMID: 39397781 PMC: 11529606. DOI: 10.1242/jcs.261673.


Enhancing terminal erythroid differentiation in human embryonic stem cells through TRIB3 overexpression.

Wang X, Cui T, Yan H, Zhao L, Zang R, Li H Heliyon. 2024; 10(18):e37463.

PMID: 39309892 PMC: 11415673. DOI: 10.1016/j.heliyon.2024.e37463.


Human red blood cells express the RNA sensor TLR7.

Lam L, Oatman E, Eckart K, Klingensmith N, Flowers E, Sayegh L Sci Rep. 2024; 14(1):15789.

PMID: 38982195 PMC: 11233670. DOI: 10.1038/s41598-024-66410-5.


Mitochondrial regulation of erythropoiesis in homeostasis and disease.

Menon V, Slavinsky M, Hermine O, Ghaffari S Br J Haematol. 2024; 205(2):429-439.

PMID: 38946206 PMC: 11619715. DOI: 10.1111/bjh.19600.


References
1.
Castrillon D, Miao L, Kollipara R, Horner J, DePinho R . Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. Science. 2003; 301(5630):215-8. DOI: 10.1126/science.1086336. View

2.
England S, McGrath K, Frame J, Palis J . Immature erythroblasts with extensive ex vivo self-renewal capacity emerge from the early mammalian fetus. Blood. 2010; 117(9):2708-17. PMC: 3062358. DOI: 10.1182/blood-2010-07-299743. View

3.
Kang Y, Sanalkumar R, OGeen H, Linnemann A, Chang C, Bouhassira E . Autophagy driven by a master regulator of hematopoiesis. Mol Cell Biol. 2011; 32(1):226-39. PMC: 3255705. DOI: 10.1128/MCB.06166-11. View

4.
Chen K, Liu J, Heck S, Chasis J, An X, Mohandas N . Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesis. Proc Natl Acad Sci U S A. 2009; 106(41):17413-8. PMC: 2762680. DOI: 10.1073/pnas.0909296106. View

5.
Franco S, De Falco L, Ghaffari S, Brugnara C, Sinclair D, Matte A . Resveratrol accelerates erythroid maturation by activation of FoxO3 and ameliorates anemia in beta-thalassemic mice. Haematologica. 2013; 99(2):267-75. PMC: 3912956. DOI: 10.3324/haematol.2013.090076. View